Targeting the protein TMEM16F may limit toxic spread of alpha-synuclein in brain

Researchers have found that a protein called TMEM16F might play a key role in how Parkinson's disease spreads in the brain. Parkinson's is partly caused by the buildup of harmful clumps of a protein called alpha-synuclein, which damages brain cells and contributes to the disease's progression. These clumps seem to spread between brain cells, worsening the condition. The team discovered that a genetic variation in the TMEM16F protein, makes it easier for these toxic clumps to spread. In lab and animal studies, reducing TMEM16F levels slowed this spread. This suggests that targeting TMEM16F might be a promising way to develop treatments that could slow or even stop the progression of Parkinson's. While this research is still in its early stages, it highlights a new potential target for therapies. Future studies will need to explore how to effectively block TMEM16F and whether this can be safely applied to humans.